65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79723D0216
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 61% complete
IDV ceiling
$6,690,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Acertis Pharmaceuticals LLC was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule on September 29, 2023. The contract has a ceiling value of $6.69 million and extends through September 28, 2028, with no set-aside restrictions applied. The contract was funded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs responsible for managing healthcare delivery to veterans in its region. Under this indefinite delivery vehicle, Acertis Pharmaceuticals is authorized to supply drugs, pharmaceuticals, and hematology-related products to Veterans Health Administration facilities and authorized federal users, with pricing and terms established in the contractor's Federal Supply Schedule price list.

The contract encompasses a broad range of pharmaceutical inventory available through the Pharmaceuticals and Drugs schedule, which enables the Veterans Integrated Service Network 12 to procure medications and related products on an as-needed basis through individual task orders placed against the established ceiling. The Federal Supply Schedule mechanism provides the contracting agency with flexibility to order products at pre-negotiated prices without conducting separate competitive procurements for each requirement. As a multiple-award contract, this vehicle allows the Veterans Integrated Service Network to distribute pharmaceutical purchases across multiple qualified vendors, promoting competition and ensuring reliable supply chain access to essential medications and hematology products supporting veteran healthcare operations.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · 42-2A product add $0
Supplemental Agreement for work within scope P00009 · 2026 public law pricing updates $0
Vendor Address Change P00008 · Admin change - company info, points of contact and signatory $0
Supplemental Agreement for work within scope P00007 · 42-2A product deletion $0
Supplemental Agreement for work within scope P00006 · 2025 public law pricing updates $0
Supplemental Agreement for work within scope P00005 · 42-2A product deletion $0
Supplemental Agreement for work within scope P00004 · SIN 42-2A establishment of dual pricing $0
Supplemental Agreement for work within scope P00003 · 65IB 42-2A product deletion $0
Other Administrative Action P00002 · 65IB administrative changes: signatory authority form and ordering contact $0
Supplemental Agreement for work within scope P00001 · 2024 public law pricing updates $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36F79723D0216?

36F79723D0216 was awarded to Acertis Pharmaceuticals LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 29, 2023.

How much is contract 36F79723D0216 worth?

36F79723D0216's own ceiling is $6,690,000.

Who can order from contract 36F79723D0216?

36F79723D0216 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79723D0216 part of a contract vehicle?

Yes. 36F79723D0216 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79723D0216 competed?

The extent of competition for 36F79723D0216 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV